10 May 2021Ended

Predicting COVID-19 Severity: Leveraging the Host Immune Response to Identify High-Risk Patients and Improve Outcomes


Estimated Turnout

upto 100
Based on previous editions


May 2021


Not Available
Claim event to edit details

Amid the COVID-19 pandemic, hospitals and intensive care units around the world have been overwhelmed by unprecedented levels of demand. Clinicians .. Read more face the difficult challenge of patient prioritization, identifying which patients to admit and how to effectively triage them within emergency room and hospital settings, and which patients can safely get the care they need at home, in isolation. Accurately predicting which COVID-19 patients are at risk of severe disease and deterioration, as well as personalized management of critically ill patients, remains challenging due to the heterogeneous nature of the virus and the limitations of available diagnostic tools. Today, however, novel host immune response technologies are yielding clues on how to best triage COVID-19 patients, showing promise in changing the paradigm in acute care patient management. Please join 360Dx and MeMed for a discussion with a panel of international experts on recent advances in the technologies used to probe the host immune response to infections, including COVID-19. Panelists will share new research and insights from their experiences on how predictive biomarkers – and the actionable information they provide – can potentially be used in clinical practice to enable more accurate, rapid diagnoses and timely interventions that can help reduce ICU admissions, the need for ventilation and, ultimately, mortality.

  • Share your Experience
  • Organizer
Logo Follow Company


USA114 Total Events / 8 Upcoming Events

More Events From The Organizer

You have no contacts. Please add contacts from below or share on social media

Send to all
No Results